These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23031147)

  • 1. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
    Irvin MR; Shimbo D; Mann DM; Reynolds K; Krousel-Wood M; Limdi NA; Lackland DT; Calhoun DA; Oparil S; Muntner P
    J Clin Hypertens (Greenwich); 2012 Oct; 14(10):694-700. PubMed ID: 23031147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Shimbo D; Levitan EB; Booth JN; Calhoun DA; Judd SE; Lackland DT; Safford MM; Oparil S; Muntner P
    J Hypertens; 2013 Feb; 31(2):370-6. PubMed ID: 23303356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
    J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
    Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
    Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.
    Shallcross AJ; Butler M; Tanner RM; Bress AP; Muntner P; Shimbo D; Ogedegbe G; Sims M; Spruill TM
    J Hum Hypertens; 2017 Jul; 31(7):474-478. PubMed ID: 28124682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
    Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
    J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: A multi-center cross-sectional study.
    Li D; Huo Z; Liu D; Gong N; Zhang F; Kong Y; Zhang Y; Su X; Xu Q; Feng J; Luo F; Wang C; Dou X; Sun G; Zhang D; Qin X; Zhang G; Lu F; Ai J
    J Clin Hypertens (Greenwich); 2022 Apr; 24(4):493-501. PubMed ID: 35235248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Tanner RM; Chaudary N; Colantonio LD; Merriman TR; Reynolds RJ; Bridges SL; Cushman M; Saag K; Limdi N; Muntner P; Howard G; Irvin MR
    J Hypertens; 2023 Jun; 41(6):1033-1039. PubMed ID: 37016935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C; Wang Y; Zhang W; Li X; Wang L; Hui R
    Clin Exp Hypertens; 2019; 41(8):753-758. PubMed ID: 30512984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
    Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.
    Bhatt H; Gamboa CM; Safford MM; Soliman EZ; Glasser SP
    J Am Soc Hypertens; 2016 Jul; 10(7):578-586.e5. PubMed ID: 27324843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent Treatment-Resistant Hypertension Among Stroke Survivors: A Transcontinental Study Assessing Impact of Race and Geography.
    Sarfo FS; Olasoji E; Banfill GP; Ovbiagele B; Simpkins AN
    Am J Hypertens; 2022 Aug; 35(8):715-722. PubMed ID: 35366323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
    Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
    J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.